Evanson Asset Management, LLC Abb Vie Inc. Transaction History

Evanson Asset Management, LLC

$1.35 Billion
Q3 2024

A detailed history of Evanson Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Evanson Asset Management, LLC holds 3,524 shares of ABBV stock, worth $717,310. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,524

Previous 3,663 3.79%

Holding current value

$717,310

Previous $628,000 10.67%

% of portfolio

0.05%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$163.84 - $199.33 $22,773 - $27,706	-139 Reduced 3.79%	3,524 $695,000
Q2 2024 Jul 12, 2024	SELL	$154.79 - $180.76 $5,882 - $6,868	-38 Reduced 1.03%	3,663 $628,000
Q1 2024 Apr 12, 2024	SELL	$159.82 - $182.1 $26,689 - $30,410	-167 Reduced 4.32%	3,701 $673,000
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $6,412 - $7,423	48 Added 1.26%	3,868 $576,000
Q4 2022 Jan 12, 2023	SELL	$138.31 - $165.87 $57,122 - $68,504	-413 Reduced 9.76%	3,820 $0
Q3 2022 Oct 12, 2022	SELL	$134.21 - $153.93 $13,555 - $15,546	-101 Reduced 2.33%	4,233 $568,000
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $34,129 - $43,390	-248 Reduced 5.41%	4,334 $664,000
Q1 2022 Apr 11, 2022	SELL	$131.98 - $163.75 $65,198 - $80,892	-494 Reduced 9.73%	4,582 $743,000
Q4 2021 Jan 19, 2022	SELL	$107.43 - $135.93 $243,758 - $308,425	-2,269 Reduced 30.89%	5,076 $687,000
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $5,107 - $5,797	48 Added 0.66%	7,345 $825,000
Q2 2021 Jul 14, 2021	SELL	$105.21 - $117.21 $31,352 - $34,928	-298 Reduced 3.92%	7,297 $822,000
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $176,058 - $193,819	1,721 Added 29.3%	7,595 $822,000
Q4 2020 Jan 22, 2021	BUY	$80.49 - $108.67 $6,922 - $9,345	86 Added 1.49%	5,874 $629,000
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $138,486 - $162,537	1,612 Added 38.6%	5,788 $507,000
Q2 2020 Jul 13, 2020	SELL	$73.37 - $98.18 $2,201 - $2,945	-30 Reduced 0.71%	4,176 $410,000
Q1 2020 Apr 24, 2020	BUY	$64.5 - $97.79 $19,930 - $30,217	309 Added 7.93%	4,206 $320,000
Q4 2019 Jan 13, 2020	BUY	$72.13 - $90.25 $20,773 - $25,992	288 Added 7.98%	3,897 $345,000
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $30,482 - $36,648	-484 Reduced 11.83%	3,609 $273,000
Q2 2019 Jul 11, 2019	SELL	$65.7 - $83.98 $25,031 - $31,996	-381 Reduced 8.52%	4,093 $298,000
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $83,696 - $98,507	-1,085 Reduced 19.52%	4,474 $361,000
Q4 2018 Jan 17, 2019	BUY	$77.85 - $96.01 $81,586 - $100,618	1,048 Added 23.23%	5,559 $512,000
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $573,469 - $637,518	-6,450 Reduced 58.84%	4,511 $427,000
Q2 2018 Jul 11, 2018	BUY	$89.78 - $106.23 $3,680 - $4,355	41 Added 0.38%	10,961 $1.02 Million
Q1 2018 Apr 05, 2018	BUY	$92.01 - $123.21 $18,862 - $25,258	205 Added 1.91%	10,920 $1.03 Million
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $6,985 - $7,660	78 Added 0.73%	10,715 $1.04 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $742,994 - $949,033	10,637	10,637 $945,000

Others Institutions Holding ABBV

# of Institutions

3,771

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evanson Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evanson Asset Management, LLC with notifications on news.

Account

Evanson Asset Management, LLC Abb Vie Inc. Transaction History